Cholesterol-modifying drugs in COVID-19. (2020)
Attributed to:
Understanding host factors that regulate the hepatitis B viral epigenome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/oxfimm/iqaa001
PubMed Identifier: 33047740
Publication URI: http://europepmc.org/abstract/MED/33047740
Type: Journal Article/Review
Volume: 1
Parent Publication: Oxford open immunology
Issue: 1
ISSN: 2633-6960